
Astera Labs, Inc. (NASDAQ:ALAB – Free Report) – Research analysts at Northland Securities boosted their FY2026 earnings per share estimates for Astera Labs in a research note issued to investors on Wednesday, November 4th. Northland Securities analyst G. Richard now expects that the company will post earnings per share of $2.99 for the year, up from their previous estimate of $2.75. Northland Securities has an “Outperform” rating and a $315.00 price objective on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $2.99 per share. Northland Securities also issued estimates for Astera Labs’ Q4 2026 earnings at $1.25 EPS, Q1 2027 earnings at $1.15 EPS, Q2 2027 earnings at $1.19 EPS, Q3 2027 earnings at $1.22 EPS, Q4 2027 earnings at $1.24 EPS and FY2027 earnings at $4.79 EPS.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The business’s revenue was up 153.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 earnings per share.
Check Out Our Latest Report on Astera Labs
Astera Labs Trading Up 6.8%
Astera Labs stock opened at $230.91 on Tuesday. The stock has a market cap of $40.36 billion, a PE ratio of 94.82 and a beta of 3.85. The stock has a 50-day moving average price of $296.41 and a 200 day moving average price of $256.51. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the second quarter valued at about $25,000. Archer Investment Corp purchased a new position in Astera Labs in the 2nd quarter worth approximately $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the 2nd quarter worth approximately $35,000. Continuum Advisory LLC purchased a new position in Astera Labs in the 2nd quarter worth approximately $37,000. Finally, GK Wealth Management LLC acquired a new stake in Astera Labs in the third quarter valued at approximately $29,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Insider Activity
In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock valued at $126,050,884 in the last ninety days. 10.40% of the stock is owned by company insiders.
Astera Labs News Summary
These are some of the ALAB news items that stood out recently:
- Neutral Sentiment: A short-interest entry claims a large increase but reports total short interest of zero shares, making the data contradictory and unhelpful as a clear trading signal.
- Negative Sentiment: ETFs were net sellers of $80.2 million of ALAB in the Nov. 6 session, indicating notable fund outflows that may add selling pressure. ETF selling report
- Negative Sentiment: Northland cut its FY2027 EPS forecast to $4.79 from $5.43 and lowered several quarterly 2027 estimates, including Q2–Q4. These reductions suggest a more cautious earnings outlook, despite the firm retaining its Outperform rating and $315 target. Analyst estimate details
About Astera Labs
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
See Also
- Five stocks we like better than Astera Labs
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
